KBP Biosciences was represented by Goodwin Procter LLP and Novo Nordisk was represented by Covington & Burling LLP in this transaction.Novo Nordisk A/S and KBP Biosciences…
- Homepage
- North America
- North America Legal Chronicle
- Novo Nordisk’s $1.3 Billion Acquisition of Ocedurenone
Novo Nordisk’s $1.3 Billion Acquisition of Ocedurenone
Tagged: 10-26-2023 Alexandra Valenti Allison Schiffman Amy Josselyn Arman Oruc Barbara Asiain Boris Segalis Brian Mukherjee Cameron Buttermore Catherine McCarty Charlie Stewart Christopher Denn Christopher Zhong Covington & Burling LLP Daniel Karelitz Danielle Fong Elizabeth Mulkey Emily Unger Goodwin Procter Gozde Guckaya Heath Ingram Janelle Dempsey Jennifer Burns Luz Julie Tibbets Karl Dragosz Katherine Hand KBP Biosciences Kevin Guan Kevin Walsh Laura Bleier Longfei Fang Madison Clausius Matt Wetzel megadeals Mohamed Sidibay Nicole Daley Novo Nordisk A Peter Laveran-Stiebar Roger Cohen S Susan Lee Timothy Holahan Tucker DeVoe Wenseng Pan Yasin Akbari
Author: Sonia Carcano
…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here